The company believes the controlled and smooth injection flow provided by this novel system will be well received by doctors and patients. Much of the clinical work was performed by Dr. Stacy Smith of Therapeutics, Inc. along with doctors from the United States, the United Kingdom and Germany. Dr. Smith observed, “Based on use in a controlled clinical setting, doctors noted improved precision in the placement of fillers, less fatigue and overall improved quality of correction when using the Smartfil™ system. Additionally, patients noted less pain and bruising with this system as compared to manual injections.”
“I was very pleased with the fast learning curve, the control in injection afforded by this system and the elimination of injector fatigue. In my very busy practice, I could envision one of these flow devices in every treatment room,” noted Dr. Steven Cohen, a plastic surgeon in San Diego.
Aesthetic Sciences President Becky Stirn stated that the company is developing its plans for commercialization. “From our years of work at Collagen Aesthetics, we learned from doctors that proper placement of dermal fillers was very important to the quality and persistence of the aesthetic result. This system gives the doctor more control over injection technique.”
Gary Petersmeyer, Chairman and CEO, noted, “The Smartfil™ system is the first product in a new category of power-assisted injection systems. We are interested in partnering with a major company in the field of dermatology who can optimize the launch of this novel device.”
Aesthetic Sciences has engaged William Blair & Company, L.L.C. to assist in its partnering efforts.
In addition to a CE Mark, Aesthetic Sciences is pursing regulatory clearance in the United States.
Aesthetic Sciences Corporation designs and develops novel polymers and injection systems for the global dermatology market. The company filler products are based on Intelimer® polymers licensed from Landec Corporation.
